Kraig Biocraft Laboratories Inc (KBLB)

[arachnodude]

Currently:

With May’s production already in progress, Kraig Labs is maintaining its momentum and remains on track to meet its full-year production capacity goals. These efforts support Kraig Labs’ broader strategy to transition recombinant spider silk from pilot-scale production to commercial viability across multiple markets.

The Overall Focus for 2025 (and beyond):

In 2025, we anticipate producing multiple tons of finished spider silk yarn, and firmly establishing Kraig Labs as the world leader in recombinant spider silk.

Beyond production, we’ve laid the groundwork for commercialization. We are entering 2025 ready to introduce our first offerings in luxury fashion and performance textiles, markets that are hungry for innovation and differentiation. The opportunity ahead is immense, and we couldn’t be more excited to see spider silk woven into products that inspire, protect, and perform.

Summation: ON TARGET!